Mild cognitive impairment as a risk factor for Parkinson's disease dementia

Movement Disorders

Volumn 32, Issue 7, 2017, Pages 1056-1065

  Hoogland, Jeroen ^a   Boel, Judith A ^a,b   de Bie, Rob M A ^a   Geskus, Ronald B ^a   Schmand, Ben A ^a,b   Dalrymple Alford, John C ^c   Marras, Connie ^d   Adler, Charles H ^e,f   Goldman, Jennifer G ^g   Tröster, Alexander I ^h   Burn, David J ⁱ   Litvan, Irene ^j   Geurtsen, Gert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c New Zealand Brain Research Institute   (New Zealand)

^d UNIVERSITY OF TORONTO   (Canada)

^e MAYO CLINIC   (United States)

^f SUN HEALTH RESEARCH INSTITUTE   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h BARROW NEUROLOGICAL INSTITUTE   (United States)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

dementia; mild cognitive impairment; neuropsychological tests; Parkinson's disease; survival analyses

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MOTOR FUNCTION TEST; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSON DISEASE WITH MILD COGNITIVE IMPAIRMENT CRITERIA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL ANALYSIS; COMPLICATION; DEMENTIA; DISEASE EXACERBATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COGNITIVE DYSFUNCTION; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85020485882     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.27002     Document Type: Article

References (39)

1. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
2. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-356.
3. Geurtsen GJ, Hoogland J, Goldman JG, et al. Parkinson's disease mild cognitive impairment: application and validation of the criteria. J Parkinsons Dis 2014;4:131-137.
4. Litvan I, Aarsland D, Adler C. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011;26:1814-1824.
5. Hely M, Reid W. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
6. Buter T, Hout A Van den, Matthews F. Dementia and survival in Parkinson disease a 12-year population study. Neurology 2008;70:1017-1022.
7. Muslimović D, Post B, Speelman J, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
8. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
9. Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009;72:1121-1126.
10. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9:1200-1213.
11. Fahn S, Elton R, Members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
12. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
13. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
14. Folstein M, Folstein S, McHugh P. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Buuren S, Groothuis-Oudshoorn K. MICE: multivariate imputation by chained equations in R. J Stat Softw 2011;45:1-67.
16. Buuren, S. Flexible Imputation of Missing Data. Boca Raton, FL: Chapman & Hall/CRC; 2012.
17. R Development Core Team. R: a language and environment for statistical computing. 2014. http://www.r-project.org. Access date: 9 March 2017.
18. White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med 2009;28:1982-1998.
19. Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation:current practice and guidelines. BMC Med Res Methodol 2009;9:57.
20. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
21. Therneau TM. A Package for Survival Analysis in S. R package version 2.37-7. 2014. http://cran.r-project.org/package=survival. Access date: 9 March 2017.
22. Harrell FE, Jr. rms: Regression Modeling Strategies. R package version 4.3-0. 2015. http://cran.r-project.org/package=rms. Access date: 9 March 2017.
23. Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
24. Dalrymple-Alford JC, Livingston L, MacAskill MR, et al. Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord 2011;26:629-636.
25. Marras C, Armstrong M, Meaney C. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord 2013;28:626-633.
26. Beach T, Adler C, Sue L. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology 2015;35:354-389.
27. de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
28. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-S14.
29. Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
30. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007;22:1077-1092.
31. Caputo M, Monastero R, Mariani E, et al. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 2008;117:455-464.
32. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
33. Hughes A, Daniel S, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
34. Goetz CG, Stebbins GT, Tilley BC. Calibration of Unified Parkinson's Disease Rating Scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord 2012;27:1239-1242.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 2000.
36. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007;22:2314-2324.
37. Ottenbacher K, Hsu Y. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil 1996;77:1226-1232.
38. Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 2010;289:18-22.
39. Goldman J, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord 2013;28:1972-1979.